Guggenheim Lifts PT on AtaiBeckley Inc. (ATAI) to $16 From $11 [Yahoo! Finance]
AtaiBeckley Inc. (ATAI)
US:NASDAQ Investor Relations:
ir.atai.net.cn
Company Research
Source: Yahoo! Finance
Inc. (NASDAQ:ATAI) to $16 from $11 on April 17, maintaining a Buy rating on the shares. The firm told investors that its recent meetings with management reinforced its “conviction” in the BPL-003 program heading into Phase 3 initiation this quarter. Is Atai Life Sciences (ATAI) the Best German Stock to Buy According to Hedge Funds? In another development, AtaiBeckley Inc. (NASDAQ:ATAI) announced on April 8 peer-reviewed Phase 2a results in CNS Drugs, exhibiting that a single intranasal dose of BPL-003 attained rapid and sustained reductions in MADRS scores from baseline in participants with treatment-resistant depression who remained on stable SSRI therapy throughout the study. BPL-003 holds FDA Breakthrough Therapy Designation. Management reported that A 66.7% antidepressant response rate was observed at Day 2 in both the 10 mg (n=6) and 12 mg (n=6) cohorts, with 83% of participants in the 10 mg cohort and 66.7% of participants in the 12 mg cohort maintaining a response at Week
Show less
Read more
Impact Snapshot
Event Time:
ATAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATAI alerts
High impacting AtaiBeckley Inc. news events
Weekly update
A roundup of the hottest topics
ATAI
News
- Psychedelic drug makers rally as Trump orders FDA to expedite reviews [Yahoo! Finance]Yahoo! Finance
- Trade Mark Registry Proceedings at the UKIPO Training Course (ONLINE EVENT: May 13, 2026) [Yahoo! Finance]Yahoo! Finance
- AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS DrugsGlobeNewswire
- AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline CatalystGlobeNewswire
- AtaiBeckley: BPL-003 Phase 3 Momentum Keeps Me Bullish [Seeking Alpha]Seeking Alpha
ATAI
Earnings
- 11/12/25 - Miss
ATAI
Sec Filings
- 4/10/26 - Form 4
- 3/24/26 - Form 4
- 3/20/26 - Form 144
- ATAI's page on the SEC website